WS #12081
Holding: newest synthesis is 127d 17h old
Bloomberg reports OpenAI is working on an AI-powered speaker for release next year, sending Sonos shares down 3% after-hours. Celcuity announces FDA approval of REVTORPYK (gedatolisib) for HR+/HER2- breast cancer, a significant milestone for the company.
OpenAI AI Speaker Threatens Sonos
Bloomberg reports OpenAI is working on an AI-powered speaker for release next year, sending Sonos shares down 3% after-hours.
Celcuity announces FDA approval of REVTORPYK (gedatolisib) for HR+/HER2- breast cancer, a significant milestone for the company.